Atlas Trials

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Clinical trial NCT00738582 · COMPLETED

Trial details

NCT number
NCT00738582
Sponsor
Morphotek
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Start date
2008-12-31
Primary completion
2011-06-30
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.